Kewaunee Scientific (NASDAQ:KEQU) Raised to “Buy” at StockNews.com

Kewaunee Scientific (NASDAQ:KEQUGet Free Report) was upgraded by StockNews.com from a “hold” rating to a “buy” rating in a research note issued to investors on Saturday.

Kewaunee Scientific Stock Performance

NASDAQ:KEQU opened at $37.90 on Friday. The company has a debt-to-equity ratio of 0.48, a quick ratio of 2.00 and a current ratio of 2.53. The stock has a market capitalization of $108.77 million, a PE ratio of 6.08 and a beta of 0.73. Kewaunee Scientific has a fifty-two week low of $16.51 and a fifty-two week high of $55.62. The company has a fifty day moving average of $34.92 and a two-hundred day moving average of $41.56.

Kewaunee Scientific (NASDAQ:KEQUGet Free Report) last released its quarterly earnings results on Wednesday, September 11th. The technology company reported $0.93 earnings per share for the quarter. Kewaunee Scientific had a net margin of 9.13% and a return on equity of 25.87%. The firm had revenue of $48.39 million during the quarter.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the company. Geode Capital Management LLC boosted its stake in Kewaunee Scientific by 8.9% during the third quarter. Geode Capital Management LLC now owns 23,784 shares of the technology company’s stock worth $792,000 after buying an additional 1,941 shares during the last quarter. Barclays PLC purchased a new position in shares of Kewaunee Scientific during the 3rd quarter worth $121,000. State Street Corp purchased a new position in shares of Kewaunee Scientific during the 3rd quarter worth $266,000. De Lisle Partners LLP boosted its position in shares of Kewaunee Scientific by 36.6% during the 3rd quarter. De Lisle Partners LLP now owns 42,958 shares of the technology company’s stock valued at $1,446,000 after acquiring an additional 11,511 shares during the last quarter. Finally, Ritholtz Wealth Management grew its holdings in shares of Kewaunee Scientific by 24.6% in the third quarter. Ritholtz Wealth Management now owns 10,913 shares of the technology company’s stock valued at $363,000 after purchasing an additional 2,156 shares during the period. 32.69% of the stock is owned by institutional investors and hedge funds.

About Kewaunee Scientific

(Get Free Report)

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.

See Also

Receive News & Ratings for Kewaunee Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kewaunee Scientific and related companies with MarketBeat.com's FREE daily email newsletter.